APAC CIOOutlook

Advertise

with us

  • Technologies
      • Artificial Intelligence
      • Big Data
      • Blockchain
      • Cloud
      • Digital Transformation
      • Internet of Things
      • Low Code No Code
      • MarTech
      • Mobile Application
      • Security
      • Software Testing
      • Wireless
  • Industries
      • E-Commerce
      • Education
      • Logistics
      • Retail
      • Supply Chain
      • Travel and Hospitality
  • Platforms
      • Microsoft
      • Salesforce
      • SAP
  • Solutions
      • Business Intelligence
      • Cognitive
      • Contact Center
      • CRM
      • Cyber Security
      • Data Center
      • Gamification
      • Procurement
      • Smart City
      • Workflow
  • Home
  • CXO Insights
  • CIO Views
  • Vendors
  • News
  • Conferences
  • Whitepapers
  • Newsletter
  • Awards
Apac
  • Artificial Intelligence

    Big Data

    Blockchain

    Cloud

    Digital Transformation

    Internet of Things

    Low Code No Code

    MarTech

    Mobile Application

    Security

    Software Testing

    Wireless

  • E-Commerce

    Education

    Logistics

    Retail

    Supply Chain

    Travel and Hospitality

  • Microsoft

    Salesforce

    SAP

  • Business Intelligence

    Cognitive

    Contact Center

    CRM

    Cyber Security

    Data Center

    Gamification

    Procurement

    Smart City

    Workflow

Menu
    • Cyber Security
    • Hotel Management
    • Workflow
    • E-Commerce
    • Business Intelligence
    • MORE
    #

    Apac CIOOutlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIOOutlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    CYFIRMA Selected by Zuellig Pharma to Strengthen Cybersecurity Posture

    With CYFIRMA's DeCYFIR platform, Zuellig Pharma has bolstered its cyber defense ammunition to accurately uncover cyberattacks at the early planning stage and take remedial actions to close vulnerabilities before hackers can compromise the netw  

    CYFIRMA Selected by Zuellig Pharma to Strengthen Cybersecurity Posture

    By

    Apac CIOOutlook | Thursday, July 01, 2021

    Stay ahead of the industry with exclusive feature stories on the top companies, expert insights and the latest news delivered straight to your inbox. Subscribe today.

    With CYFIRMA's DeCYFIR platform, Zuellig Pharma has bolstered its cyber defense ammunition to accurately uncover cyberattacks at the early planning stage and take remedial actions to close vulnerabilities before hackers can compromise the network.

    FREMONT, CA: CYFIRMA, a threat discovery and cyber-intelligence platform company funded by Goldman Sachs, Zodius Capital, and Z3Partners, announced that Zuellig Pharma, a leading healthcare services provider in Asia, has selected DeCYFIR, a cloud-based, AI-powered cybersecurity platform, to gain further visibility into its external threat landscape to uncover hacking campaigns and avert cyberattacks.

    In the last 18 months, the COVID-19 pandemic has seen the global healthcare industry falling victim to cybercriminals taking advantage of the chaos. According to CYFIRMA researchers, cyberattacks on healthcare more than doubled in 2020. COVID-19 response efforts, including vaccine research and supply chain, were the largest focus of these targeted campaigns.

    "As a healthcare services company delivering life-saving medicines to those who need them the most, we own and operate some of the most advanced cold chain facilities, managing temperature-sensitive medicines through innovative and digitalized processes. The rapidly evolving threat landscape in the healthcare industry has shown us the importance of managing cybersecurity in dynamic ways, particularly as we continue rolling out more digitalization initiatives. CYFIRMA's DeCYFIR will guide us in our response to cyber risks by providing us with real-time insights and early warnings to malicious activities targeting us," said Mike Brewster, Vice President Technology, Zuellig Pharma.

    With CYFIRMA's DeCYFIR platform, Zuellig Pharma has bolstered its cyber defense ammunition to accurately uncover cyberattacks at the early planning stage and take remedial actions to close vulnerabilities before hackers can compromise the network. The platform enables further visibility into the external threat landscape by monitoring the dark web, hacker forums, and various closed communities to look for threat indicators that would signal cyber criminals planning to exploit security weaknesses that could lead to business disruption.

    "We are honored to be working with Zuellig Pharma to deploy our DeCYFIR platform, which will play a pivotal role in helping them fend off cybercriminals who are out to pilfer intellectual property, conduct corporate espionage, cause business disruption, and damage brand and reputation. Cybercrime has escalated rapidly in recent times, and this is a clear sign that businesses need to relook at how they are currently managing their cybersecurity strategies and programs. DeCYFIR's ability to predict imminent attacks will give defenders the much-needed edge over cybercriminals," said Kumar Ritesh, Founder, and CEO, CYFIRMA. "

    More in News

    AI's Role in Apac's Digital Transformation Journey

    AI's Role in Apac's Digital Transformation Journey

    Influence of AI on Supply Chain Management

    Influence of AI on Supply Chain Management

    Role of Blockchain in Fostering a Trust-Based Economy

    Role of Blockchain in Fostering a Trust-Based Economy

    Revolutionizing Healthcare Through 5G Technology

    Revolutionizing Healthcare Through 5G Technology

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Copyright © 2025 APAC CIOOutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy and Anti Spam Policy 

    Home |  CXO Insights |   Whitepapers |   Subscribe |   Conferences |   Sitemaps |   About us |   Advertise with us |   Editorial Policy |   Feedback Policy |  

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/cyfirma-selected-by-zuellig-pharma-to-strengthen-cybersecurity-posture-nwid-8282.html